Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2.

Diabetology & metabolic syndrome

Valerio CM, de Almeida JS, Moreira RO, Aguiar LBS, Siciliano PO, Carvalho DP, Godoy-Matos AF.
PMID: 28450900
Diabetol Metab Syndr. 2017 Apr 24;9:26. doi: 10.1186/s13098-017-0226-0. eCollection 2017.

BACKGROUND: Dipeptidyl peptidase-4 (DDP4) is an enzyme responsible for glucagon-like peptide-1 inactivation and plays an important role in glucose metabolism.OBJECTIVE: The aim of this study was to evaluate DPP4 levels in patients with familial partial lipodystrophy type 2 (FPLD2)...

Cite
Valerio CM, de Almeida JS, Moreira RO, et al. Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2. Diabetol Metab Syndr. 2017;9:26doi: 10.1186/s13098-017-0226-0.
Valerio, C. M., de Almeida, J. S., Moreira, R. O., Aguiar, L. B. S., Siciliano, P. O., Carvalho, D. P., & Godoy-Matos, A. F. (2017). Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2. Diabetology & metabolic syndrome, 926. https://doi.org/10.1186/s13098-017-0226-0
Valerio, Cynthia Melissa, et al. "Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2." Diabetology & metabolic syndrome vol. 9 (2017): 26. doi: https://doi.org/10.1186/s13098-017-0226-0
Valerio CM, de Almeida JS, Moreira RO, Aguiar LBS, Siciliano PO, Carvalho DP, Godoy-Matos AF. Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2. Diabetol Metab Syndr. 2017 Apr 24;9:26. doi: 10.1186/s13098-017-0226-0. eCollection 2017. PMID: 28450900; PMCID: PMC5404683.
Copy Download .nbib Format: NLM
The role of glucagon on type 2 diabetes at a glance.

Diabetology & metabolic syndrome

Godoy-Matos AF.
PMID: 25177371
Diabetol Metab Syndr. 2014 Aug 24;6(1):91. doi: 10.1186/1758-5996-6-91. eCollection 2014.

The opposite effects of insulin and glucagon in fuel homeostasis, the paracrine/endocrine inhibitory effects of insulin on glucagon secretion and the hyperglucagonemia in the pathogenesis of type 2 diabetes (T2D) have long been recognized. Inappropriately increased alpha-cell function importantly...

Cite
Godoy-Matos AF. The role of glucagon on type 2 diabetes at a glance. Diabetol Metab Syndr. 2014;6(1):91doi: 10.1186/1758-5996-6-91.
Godoy-Matos, A. F. (2014). The role of glucagon on type 2 diabetes at a glance. Diabetology & metabolic syndrome, 6(1), 91. https://doi.org/10.1186/1758-5996-6-91
Godoy-Matos, Amélio F. "The role of glucagon on type 2 diabetes at a glance." Diabetology & metabolic syndrome vol. 6,1 (2014): 91. doi: https://doi.org/10.1186/1758-5996-6-91
Godoy-Matos AF. The role of glucagon on type 2 diabetes at a glance. Diabetol Metab Syndr. 2014 Aug 24;6(1):91. doi: 10.1186/1758-5996-6-91. eCollection 2014. PMID: 25177371; PMCID: PMC4148933.
Copy Download .nbib Format: NLM
Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy.

Diabetology & metabolic syndrome

Godoy-Matos AF, Valerio CM, Moreira RO, Momesso DP, Bittencourt LK.
PMID: 30275911
Diabetol Metab Syndr. 2018 Sep 26;10:71. doi: 10.1186/s13098-018-0375-9. eCollection 2018.

BACKGROUND: To study pancreatic fat deposition and beta-cell function in familial partial lipodystrophy (FPLD) patients.METHODS: In a cross-sectional study, eleven patients with FPLD, and eight healthy volunteers were matched for age and body mass index and studied at a...

Cite
Godoy-Matos AF, Valerio CM, Moreira RO, et al. Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy. Diabetol Metab Syndr. 2018;10:71doi: 10.1186/s13098-018-0375-9.
Godoy-Matos, A. F., Valerio, C. M., Moreira, R. O., Momesso, D. P., & Bittencourt, L. K. (2018). Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy. Diabetology & metabolic syndrome, 1071. https://doi.org/10.1186/s13098-018-0375-9
Godoy-Matos, Amelio F, et al. "Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy." Diabetology & metabolic syndrome vol. 10 (2018): 71. doi: https://doi.org/10.1186/s13098-018-0375-9
Godoy-Matos AF, Valerio CM, Moreira RO, Momesso DP, Bittencourt LK. Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy. Diabetol Metab Syndr. 2018 Sep 26;10:71. doi: 10.1186/s13098-018-0375-9. eCollection 2018. PMID: 30275911; PMCID: PMC6158829.
Copy Download .nbib Format: NLM
Erratum: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation.

Diabetology & metabolic syndrome

Valerio CM, Zajdenverg L, de Oliveira JE, Mory PB, Moises RS, Godoy-Matos AF.
PMID: 25774228
Diabetol Metab Syndr. 2015 Mar 14;7:19. doi: 10.1186/s13098-015-0007-6. eCollection 2015.

[This corrects the article DOI: 10.1186/1758-5996-4-40.].

Cite
Valerio CM, Zajdenverg L, de Oliveira JE, et al. Erratum: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2015;7:19doi: 10.1186/s13098-015-0007-6.
Valerio, C. M., Zajdenverg, L., de Oliveira, J. E., Mory, P. B., Moises, R. S., & Godoy-Matos, A. F. (2015). Erratum: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetology & metabolic syndrome, 719. https://doi.org/10.1186/s13098-015-0007-6
Valerio, Cynthia M, et al. "Erratum: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation." Diabetology & metabolic syndrome vol. 7 (2015): 19. doi: https://doi.org/10.1186/s13098-015-0007-6
Valerio CM, Zajdenverg L, de Oliveira JE, Mory PB, Moises RS, Godoy-Matos AF. Erratum: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2015 Mar 14;7:19. doi: 10.1186/s13098-015-0007-6. eCollection 2015. PMID: 25774228; PMCID: PMC4359429.
Copy Download .nbib Format: NLM
Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome.

Diabetology & metabolic syndrome

Guedes EP, Madeira E, Mafort TT, Madeira M, Moreira RO, Mendonça LM, Godoy-Matos AF, Lopes AJ, Farias ML.
PMID: 28031749
Diabetol Metab Syndr. 2016 Dec 19;8:81. doi: 10.1186/s13098-016-0197-6. eCollection 2016.

BACKGROUND: The aim of this study was to investigate the effects of a 6-month treatment with intragastric balloon (IGB) on body composition and depressive/anxiety symptoms in obese individuals with metabolic syndrome (MS).METHODS: Fifty patients (aged 18-50 years) with obesity...

Cite
Guedes EP, Madeira E, Mafort TT, et al. Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome. Diabetol Metab Syndr. 2016;8:81doi: 10.1186/s13098-016-0197-6.
Guedes, E. P., Madeira, E., Mafort, T. T., Madeira, M., Moreira, R. O., Mendonça, L. M., Godoy-Matos, A. F., Lopes, A. J., & Farias, M. L. (2016). Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome. Diabetology & metabolic syndrome, 881. https://doi.org/10.1186/s13098-016-0197-6
Guedes, Erika P, et al. "Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome." Diabetology & metabolic syndrome vol. 8 (2016): 81. doi: https://doi.org/10.1186/s13098-016-0197-6
Guedes EP, Madeira E, Mafort TT, Madeira M, Moreira RO, Mendonça LM, Godoy-Matos AF, Lopes AJ, Farias ML. Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome. Diabetol Metab Syndr. 2016 Dec 19;8:81. doi: 10.1186/s13098-016-0197-6. eCollection 2016. PMID: 28031749; PMCID: PMC5168847.
Copy Download .nbib Format: NLM
Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation.

Diabetology & metabolic syndrome

Valerio CM, Zajdenverg L, de Oliveira JE, Mory PB, Moyses RS, Godoy-Matos AF.
PMID: 22938045
Diabetol Metab Syndr. 2012 Aug 31;4(1):40. doi: 10.1186/1758-5996-4-40.

BACKGROUND: Familial partial lipodystrophies (FPLD) are clinically heterogeneous disorders characterized by selective loss of adipose tissue, insulin resistance and metabolic complications. Until genetic studies become available for clinical practice, clinical suspicion and pattern of fat loss are the only...

Cite
Valerio CM, Zajdenverg L, de Oliveira JE, et al. Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012;4(1):40doi: 10.1186/1758-5996-4-40.
Valerio, C. M., Zajdenverg, L., de Oliveira, J. E., Mory, P. B., Moyses, R. S., & Godoy-Matos, A. F. (2012). Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetology & metabolic syndrome, 4(1), 40. https://doi.org/10.1186/1758-5996-4-40
Valerio, Cynthia M, et al. "Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation." Diabetology & metabolic syndrome vol. 4,1 (2012): 40. doi: https://doi.org/10.1186/1758-5996-4-40
Valerio CM, Zajdenverg L, de Oliveira JE, Mory PB, Moyses RS, Godoy-Matos AF. Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012 Aug 31;4(1):40. doi: 10.1186/1758-5996-4-40. PMID: 22938045; PMCID: PMC3524775.
Copy Download .nbib Format: NLM
Evaluation of epicardial adipose tissue in familial partial lipodystrophy.

Diabetology & metabolic syndrome

Godoy-Matos AF, Valério CM, Bragança JB, Oliveira Rde A, Zagury RL, Lustosa Rde P, Camargo GC, Nascimento CA, Moreira RO.
PMID: 25859279
Diabetol Metab Syndr. 2015 Apr 01;7:29. doi: 10.1186/s13098-015-0024-5. eCollection 2015.

BACKGROUND: Dunnigan type Familial Partial Lipodystrophy (FPLD) is characterized by loss of subcutaneous fat from the limbs and excessive accumulation on the visceral adipose tissue (VAT). Affected individuals have insulin resistance (IR), diabetes, dyslipidemia and early cardiovascular (CV) events,...

Cite
Godoy-Matos AF, Valério CM, Bragança JB, et al. Evaluation of epicardial adipose tissue in familial partial lipodystrophy. Diabetol Metab Syndr. 2015;7:29doi: 10.1186/s13098-015-0024-5.
Godoy-Matos, A. F., Valério, C. M., Bragança, J. B., Oliveira, R. d. e. . A., Zagury, R. L., Lustosa, R. d. e. . P., Camargo, G. C., Nascimento, C. A., & Moreira, R. O. (2015). Evaluation of epicardial adipose tissue in familial partial lipodystrophy. Diabetology & metabolic syndrome, 729. https://doi.org/10.1186/s13098-015-0024-5
Godoy-Matos, Amélio Fernando, et al. "Evaluation of epicardial adipose tissue in familial partial lipodystrophy." Diabetology & metabolic syndrome vol. 7 (2015): 29. doi: https://doi.org/10.1186/s13098-015-0024-5
Godoy-Matos AF, Valério CM, Bragança JB, Oliveira Rde A, Zagury RL, Lustosa Rde P, Camargo GC, Nascimento CA, Moreira RO. Evaluation of epicardial adipose tissue in familial partial lipodystrophy. Diabetol Metab Syndr. 2015 Apr 01;7:29. doi: 10.1186/s13098-015-0024-5. eCollection 2015. PMID: 25859279; PMCID: PMC4391299.
Copy Download .nbib Format: NLM
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.

Diabetology & metabolic syndrome

Godoy-Matos AF, Silva Júnior WS, Valerio CM.
PMID: 32684985
Diabetol Metab Syndr. 2020 Jul 14;12:60. doi: 10.1186/s13098-020-00570-y. eCollection 2020.

BACKGROUND: The prevalence of non-alcoholic fatty liver disease (NAFLD) has been increasing rapidly. It is nowadays recognized as the most frequent liver disease, affecting a quarter of global population and regularly coexisting with metabolic disorders such as type 2...

Cite
Godoy-Matos AF, Silva Júnior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12:60doi: 10.1186/s13098-020-00570-y.
Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020). NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & metabolic syndrome, 1260. https://doi.org/10.1186/s13098-020-00570-y
Godoy-Matos, Amélio F, et al. "NAFLD as a continuum: from obesity to metabolic syndrome and diabetes." Diabetology & metabolic syndrome vol. 12 (2020): 60. doi: https://doi.org/10.1186/s13098-020-00570-y
Godoy-Matos AF, Silva Júnior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020 Jul 14;12:60. doi: 10.1186/s13098-020-00570-y. eCollection 2020. PMID: 32684985; PMCID: PMC7359287.
Copy Download .nbib Format: NLM
Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome.

Diabetology & metabolic syndrome

Guedes EP, Madeira E, Mafort TT, Madeira M, Moreira RO, Mendonça LM, Godoy-Matos AF, Lopes AJ, Farias ML.
PMID: 24364839
Diabetol Metab Syndr. 2013 Dec 23;5(1):82. doi: 10.1186/1758-5996-5-82.

BACKGROUND: Several studies point to a correlation between obesity and the severity of depressive and anxiety symptoms in children and adults, but there are still some controversial points about this association. The aim of this study is to investigate...

Cite
Guedes EP, Madeira E, Mafort TT, et al. Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome. Diabetol Metab Syndr. 2013;5(1):82doi: 10.1186/1758-5996-5-82.
Guedes, E. P., Madeira, E., Mafort, T. T., Madeira, M., Moreira, R. O., Mendonça, L. M., Godoy-Matos, A. F., Lopes, A. J., & Farias, M. L. (2013). Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome. Diabetology & metabolic syndrome, 5(1), 82. https://doi.org/10.1186/1758-5996-5-82
Guedes, Erika P, et al. "Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome." Diabetology & metabolic syndrome vol. 5,1 (2013): 82. doi: https://doi.org/10.1186/1758-5996-5-82
Guedes EP, Madeira E, Mafort TT, Madeira M, Moreira RO, Mendonça LM, Godoy-Matos AF, Lopes AJ, Farias ML. Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome. Diabetol Metab Syndr. 2013 Dec 23;5(1):82. doi: 10.1186/1758-5996-5-82. PMID: 24364839; PMCID: PMC3913787.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries